Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Elevance Health, Inc. (ELV:NYSE), powered by AI.
Elevance Health, Inc. is currently trading at $397.80. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Elevance Health, Inc. on Alpha Lenz.
Elevance Health, Inc.'s P/E ratio is 15.5.
“Elevance Health, Inc. trades at a P/E of 15.5 (fair value) with solid ROE of 13.3%.”
Ask for details →Elevance Health, Inc. is a major provider of managed healthcare services, specializing in delivering a comprehensive suite of health insurance products and related services across the United States. The company operates as an independent licensee of the Blue Cross and Blue Shield Association and serves nearly 46 million medical members, making it one of the leading health insurers in the American market. Elevance Health’s offerings encompass medical, dental, vision, life, disability, and behavioral health insurance, as well as long-term care and medical expense management products. Its broad client base includes individuals, employers, and government programs, helping to manage the health needs of diverse populations. With significant revenues and a strong presence in both the group and individual insurance segments, Elevance Health plays a vital role in supporting access to healthcare and controlling costs within the industry. The company’s size and reach position it as a key participant in shaping healthcare delivery and innovation in the United States marketplace.
“Elevance Health, Inc. trades at a P/E of 15.5 (fair value) with solid ROE of 13.3%.”
Ask for details →Elevance Health, Inc. (ticker: ELV) is a company listed on NYSE in the Healthcare sector (Healthcare Plans). It has approximately 104,200 employees. Market cap is $87.8B.
The current price is $397.8 with a P/E ratio of 15.51x and P/B of 2x.
ROE is 13.29%. Annual revenue is $199.1B.